For the first time, the clinical pharmacy community has carried out a special investigation in the field of tumor immunology

"We still have deficiencies in the field of original drug research and development.

Ding Jian, Academician of Chinese Academy of Engineering, Dean of School of Pharmacy, University of Chinese Academy of Sciences

The first special research, training, and popular science project in the field of tumor immunology in the domestic clinical pharmacy field, the "Bright China-Oncology Pharmacist Empowerment Program" was launched recently.

The launch of a large number of targeted and immunotherapeutic drugs has opened a new chapter in precision treatment in the field of cancer in my country.

In fact, there are still big differences in the practice of standardized treatment, rational drug use, and pharmacy professional team building in my country's hospitals at all levels, especially in grassroots hospitals.

Professor Huang Dongsheng made a speech

Professor Lv Qianzhou, director of the Pharmacy Department of Zhongshan Hospital affiliated to Fudan University, introduced that this “Oncology Pharmacist Empowerment Program” will carry out a large sample of oncological pharmacist surveys across the country, focusing on the construction of the hospital’s clinical pharmacist team, the current status of oncology pharmacists’ pharmaceutical services, and oncology The pharmacist conducts ground-breaking investigations on the current status of the development of clinical pharmacy and pharmacists on the four dimensions of the current status of immunological drug full-process pharmacy services and the development needs of oncology pharmacists' pharmacy capabilities, analyzes the status of the development of clinical pharmacy and pharmacists at the national and regional levels, and formulates targeted solutions.

Professor Ma Yabin, director of the Department of Pharmacy of Shanghai Oriental Hospital, also said: “Under the new situation, clinical pharmacy also needs to keep pace with the times.